Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Pops Richard F
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,303,786    

Indirect Shares

   0      
Direct Value   $38,865,028    

Indirect Value

   $0      
Total Shares   1,303,786      
Total Value   $38,865,028      


Neurocrine Biosciences Inc $4,407,522 Alkermes Plc $28,559,932 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,407,522 Alkermes Plc $28,559,932 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 31,611 2005-11-23 0    Premium*  
            Alkermes Plc ALKS Director and CEO, Alke... 2024-02-08 1,179,675 2011-09-16 0    Premium*  
            Epizyme, Inc. EPZM Director 2013-05-30 60,000 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2019-01-25 32,500 0    Premium*  
* Premium Members only  

Records found :    259         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-10-17 4 AS $20.00 $58,000 D/D (2,900) 348,173 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-11-12 4 AS $20.25 $244,966 D/D (12,100) 348,173 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-11-12 4 OE $7.36 $89,056 D/D 12,100 360,273 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-11-18 4 OE $0.00 $0 D/D 125,000 473,173 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2012-11-18 4 D $19.49 $1,015,936 D/D (52,126) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-01-14 4 OE $9.97 $498,500 D/D 50,000 471,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-01-14 4 AS $21.91 $1,095,650 D/D (50,000) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-01-22 4 AS $22.30 $1,114,775 D/D (50,000) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-01-22 4 OE $9.97 $498,500 D/D 50,000 471,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-19 4 OE $9.97 $498,500 D/D 50,000 471,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-19 4 AS $20.96 $1,048,155 D/D (50,000) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-25 4 AS $20.72 $336,655 D/D (16,250) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-25 4 OE $9.97 $162,013 D/D 16,250 437,297 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2013-03-28 4 OE $10.60 $127,200 D/D 12,000 12,000 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2013-03-28 4 D $12.15 $127,198 D/D (10,469) 1,531 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-17 4 OE $0.00 $0 D/D 8,125 429,172 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-17 4 D $31.69 $121,563 D/D (3,836) 425,336 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-20 4 D $31.04 $119,038 D/D (3,835) 429,626 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-20 4 OE $0.00 $0 D/D 8,125 433,461 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-21 4 OE $0.00 $0 D/D 8,125 437,751 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-05-21 4 D $31.98 $122,643 D/D (3,835) 433,916 0 -
EPZM Epizyme, Inc. Director   –       •      –    2013-05-30 3 IO $0.00 $0 D/D 0 60,000 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-07-01 4 AS $29.84 $2,984,100 D/D (100,000) 433,916 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-07-01 4 OE $12.16 $1,336,500 D/D 100,000 483,916 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-07-08 4 OE $12.16 $1,336,500 D/D 100,000 483,916 0 -
  259  Records found
  1   2  3   4   5   6   7   8   9   10   11      
  Page 2 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us